270 related articles for article (PubMed ID: 18477622)
1. The impact of hyperprolactinaemia on sexual function in patients with psychosis.
Smith SM
J Psychopharmacol; 2008 Mar; 22(2 Suppl):63-9. PubMed ID: 18477622
[TBL] [Abstract][Full Text] [Related]
2. The evolution of hyperprolactinaemia as an entity in psychiatric patients.
Kohen D; Wildgust HJ
J Psychopharmacol; 2008 Mar; 22(2 Suppl):6-11. PubMed ID: 18477616
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic-induced hyperprolactinemia and sexual dysfunction.
Compton MT; Miller AH
Psychopharmacol Bull; 2002; 36(1):143-64. PubMed ID: 12397853
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.
Holt RI; Peveler RC
Clin Endocrinol (Oxf); 2011 Feb; 74(2):141-7. PubMed ID: 20455888
[TBL] [Abstract][Full Text] [Related]
5. Hyperprolactinaemia and antipsychotic therapy in schizophrenia.
Hummer M; Huber J
Curr Med Res Opin; 2004; 20(2):189-97. PubMed ID: 15006013
[TBL] [Abstract][Full Text] [Related]
6. Prolactin awareness: an essential consideration for physical health in schizophrenia.
Montejo AL
Eur Neuropsychopharmacol; 2008 May; 18 Suppl 2():S108-14. PubMed ID: 18346598
[TBL] [Abstract][Full Text] [Related]
7. Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.
Holt RI
J Psychopharmacol; 2008 Mar; 22(2 Suppl):28-37. PubMed ID: 18477618
[TBL] [Abstract][Full Text] [Related]
8. Sexual side effects associated with conventional and atypical antipsychotics.
Compton MT; Miller AH
Psychopharmacol Bull; 2001; 35(3):89-108. PubMed ID: 12397881
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic-induced hyperprolactinaemia.
Inder WJ; Castle D
Aust N Z J Psychiatry; 2011 Oct; 45(10):830-7. PubMed ID: 21714721
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic-induced hyperprolactinemia.
Bostwick JR; Guthrie SK; Ellingrod VL
Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
[TBL] [Abstract][Full Text] [Related]
11. A review of the association between antipsychotic use and hyperprolactinaemia.
Bushe C; Shaw M; Peveler RC
J Psychopharmacol; 2008 Mar; 22(2 Suppl):46-55. PubMed ID: 18477620
[TBL] [Abstract][Full Text] [Related]
12. Sexual dysfunction in schizophrenia: focus on recent evidence.
Baggaley M
Hum Psychopharmacol; 2008 Apr; 23(3):201-9. PubMed ID: 18338766
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.
O'Keane V
J Psychopharmacol; 2008 Mar; 22(2 Suppl):70-5. PubMed ID: 18477623
[TBL] [Abstract][Full Text] [Related]
14. [Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy].
Riecher-Rössler A; Schmid C; Bleuer S; Birkhäuser M
Neuropsychiatr; 2009; 23(2):71-83. PubMed ID: 19573500
[TBL] [Abstract][Full Text] [Related]
15. [Sexual dysfunctions induced by antidepressants and antipsychotics].
Martin-Du PR; Baumann P
Rev Med Suisse; 2008 Mar; 4(150):758-62. PubMed ID: 18476641
[TBL] [Abstract][Full Text] [Related]
16. Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.
Cookson J; Hodgson R; Wildgust HJ
J Psychopharmacol; 2012 May; 26(5 Suppl):42-51. PubMed ID: 22472310
[TBL] [Abstract][Full Text] [Related]
17. The emerging physical health challenges of antipsychotic associated hyperprolactinaemia in patients with serious mental illness.
Dursun SM; Wildgust HJ; Strickland P; Goodwin GM; Citrome L; Lean M
J Psychopharmacol; 2008 Mar; 22(2 Suppl):3-5. PubMed ID: 18477615
[No Abstract] [Full Text] [Related]
18. Understanding osteoporosis.
Javaid MK; Holt RI
J Psychopharmacol; 2008 Mar; 22(2 Suppl):38-45. PubMed ID: 18477619
[TBL] [Abstract][Full Text] [Related]
19. Comment on Hyperprolactinaemia and antipsychotic therapy in schizophrenia.
Howes OD; Smith S; Aitchison KJ
Curr Med Res Opin; 2004 Oct; 20(10):1649. PubMed ID: 15462698
[No Abstract] [Full Text] [Related]
20. Hyperprolactinaemia in early psychosis-not only due to antipsychotics.
Aston J; Rechsteiner E; Bull N; Borgwardt S; Gschwandtner U; Riecher-Rössler A
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1342-4. PubMed ID: 20188136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
